Report of Foreign Issuer (6-k)

 

---

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2015

Commission File Number: 001-34975

IMRIS INC.
(Translation of registrant's name into English)

100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

☐ Form 20-F

☒ Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

---

 

 

 

INCORPORATION BY REFERENCE

 

Exhibit 99.1 to this Form 6-K shall be incorporated by reference as an exhibit to the Registration Statement No. 333-199241 of IMRIS Inc. on Form F-3.

 

DOCUMENTS FILED AS PART OF THIS FORM 6-K

 

See the Exhibit Index hereto.

 

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

	IMRIS Inc.
	(Registrant)
Date: May 19, 2015	By:	/s/ Jay D. Miller
		_____________________________________
	Name:	Jay D. Miller
	Title:	President and CEO

 

---

 

EXHIBIT INDEX

99.1	Material Change Report
99.2	News Release Dated May 19, 2015 - IMRIS Executive Vice Presidents of Global Sales and Global Customer Service Leave the Company

 

 

---

 

Exhibit 99.1

 

 

FORM 51-102F3

Material Change Report

 

Item 1		Name and Address of Company
		IMRIS Inc. (the “ Company ”)
		100 - 1370 Sony Place
		Winnipeg, Manitoba
		Canada, R3T 1N5
Item 2		Date of Material Change
		May 15, 2015
Item 3		News Release
		News release attached as Schedule “A” was disseminated on May 19, 2015 via Canada NewsWire.
Item 4		Summary of Material Change
		Effective May 15, 2015, Mike Fritts, Executive Vice President, Global Customer Service, left the Company. Mr. Fritts has served as IMRIS’ EVP Global Customer Service since 2013. Effective May 16, 2015, Mark Reade, Executive Vice President, Global Sales, left the Company. Mr. Reade has served as IMRIS’ EVP of Global Sales since 2010.
Item 5		Full Description of Material Change
		5.1	Full Description of Material Change
		See news release attached hereto as Schedule “A” dated May 19, 2015.
		5.2	Disclosure for Restructuring Transactions
		N/A
Item 6		Reliance on subsection 7.1(2) or (3) of National Instrument 51-102
		N/A
Item 7		Omitted Information
		N/A.
Item 8		Executive Officer
		Name of Executive Officer:		Jay D. Miller
		Title:		President and CEO
		Telephone Number:		763-203-6300
Item 9		Date of Report
		May 19, 2015

 

 

 

 

 

Schedule “A”

 

IMRIS Executive Vice Presidents of Global Sales and

Global Customer Service Leave the Company

 

 

MINNEAPOLIS, MN, May 19, 2015 - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) today announced that Mike Fritts, Executive Vice President, Global Customer Service, and Mark Reade, Executive Vice President, Global Sales, have left the Company. Mr. Fritts departed effective May 15, 2015 and has served as IMRIS’ EVP of Global Customer Service since 2013. Mr. Reade departed effective May 16, 2015 and has served as IMRIS’ EVP of Global Sales since 2010.

 

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular, spinal and cerebrovascular markets and have been selected by leading medical institutions around the world. For more information, visit www.imris.com.

 

Forward-Looking Statements

This press release may contain or refer to forward-looking information based on current expectations. In some cases, forward-looking statements can be identified by terminology such as “anticipate”, “may”, “expect”, “believe”, “prospective”, “continue” or the negative of these terms or other similar expressions concerning matters that are not historical facts. These statements should not be understood as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that actual results will be consistent with such statements. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. These forward-looking statements are made as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances.

 

For further information, please contact:
Jeffery Bartels
Director - Finance
IMRIS Inc.
Tel: [phone]
Email: [e-mail]

# # #

Exhibit 99.2

 

 

IMRIS Executive Vice Presidents of Global Sales and Global Customer Service Leave the Company

MINNEAPOLIS, MN, May 19, 2015 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) today announced that Mike Fritts, Executive Vice President, Global Customer Service, and Mark Reade, Executive Vice President, Global Sales, have left the Company.  Mr. Fritts departed effective May 15, 2015 and has served as IMRIS' EVP of Global Customer Service since 2013.  Mr. Reade departed effective May 16, 2015 and has served as IMRIS' EVP of Global Sales since 2010.

About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre – a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular, spinal and cerebrovascular markets and have been selected by leading medical institutions around the world. For more information, visit www.imris.com.

Forward-Looking Statements
This press release may contain or refer to forward-looking information based on current expectations.  In some cases, forward-looking statements can be identified by terminology such as "anticipate", "may", "expect", "believe", "prospective", "continue" or the negative of these terms or other similar expressions concerning matters that are not historical facts.  These statements should not be understood as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that actual results will be consistent with such statements. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results.  These forward-looking statements are made as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances.

SOURCE IMRIS Inc.

 

%CIK: 0001489161

For further information: Jeffery Bartels, Director - Finance, IMRIS Inc., Tel: [phone], Email: [e-mail]

CO: IMRIS Inc.

CNW 07:01e 19-MAY-15